Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $1.4 million.

  • Palisade Bio's Accounts Payables rose 28961.75% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 28961.75%. This contributed to the annual value of $1.1 million for FY2024, which is 5830.95% up from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's Accounts Payables is $1.4 million, which was up 28961.75% from $1.4 million recorded in Q2 2025.
  • Palisade Bio's Accounts Payables' 5-year high stood at $1.8 million during Q4 2022, with a 5-year trough of $366000.0 in Q3 2024.
  • Its 5-year average for Accounts Payables is $1.0 million, with a median of $995500.0 in 2022.
  • As far as peak fluctuations go, Palisade Bio's Accounts Payables plummeted by 6147.37% in 2024, and later soared by 28961.75% in 2025.
  • Over the past 5 years, Palisade Bio's Accounts Payables (Quarter) stood at $1.4 million in 2021, then grew by 27.19% to $1.8 million in 2022, then plummeted by 60.32% to $698000.0 in 2023, then skyrocketed by 58.31% to $1.1 million in 2024, then grew by 29.05% to $1.4 million in 2025.
  • Its Accounts Payables was $1.4 million in Q3 2025, compared to $1.4 million in Q2 2025 and $745000.0 in Q1 2025.